MMV ESAC member Dennis Smith recognized by the International Society for the Study of Xenobiotics 28 February 2023
Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis 28 February 2023 PLoS Pathog
A pharmacometrics approach to assess the feasibility of capillary microsampling to replace venous sampling in clinical studies: Tafenoquine case study 28 February 2023 Br J Clin Pharmacol
Assessment of the drugability of initial malaria infection through miniaturized sporozoite assays and high-throughput screening 23 February 2023 Commun Biol
Treatment of uncomplicated P. falciparum malaria in the first trimester of pregnancy: Implementation of the revised WHO treatment guidelines (25 November 2022) 22 February 2023
Characterizing the blood stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum 16 February 2023 Clinical Infectious Diseases
Fast-Killing Tyrosine Amide ((S)-SW228703) with Blood- and Liver-Stage Antimalarial Activity Associated with the Cyclic Amine Resistance Locus (PfCARL) 10 February 2023
The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Viability after Antimalarial Treatment In Vitro 22 January 2023 Pharmaceuticals (Basel)
Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria 2 January 2023 Malar J
A pharmacokinetic-pharmacodynamic model for chemoprotective agents against malaria 31 December 2022 CPT Pharmacometrics Syst Pharmacol
Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review 31 December 2022 Infect Dis Ther
Medicines for Malaria Venture and the Africa CDC sign Memorandum of Understanding to support African manufacturers 15 December 2022
Overexpression of hepatocyte EphA2 enhances liver-stage infection by Plasmodium vivax 12 December 2022 Sci Rep
Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial 30 November 2022 EBioMedicine
WHO gives ‘strong recommendation’ supporting use of antimalarial drug to treat pregnant women in the first trimester 28 November 2022
Strong recommendation for pyronaridine-artesunate in revised WHO Malaria Treatment Guidelines 25 November 2022